Pretreatment prognostic factors and scor
โ
T. Cerny; H. Anderson; V. Bramwell; N. Thatcher; V. Blair
๐
Article
๐
1987
๐
John Wiley and Sons
๐
French
โ 409 KB
๐ 1 views
In 407 patients with small-cell lung cancer (SCLC), 61 pretreatment variables were evaluated in a Cox multiple regression analysis to assess their prognostic value. All patients received short-term intensive regimens (cyclophosphamide, etoposide and methotrexate or ifosfamide and etoposide, both fol